Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC40121
(Z-DEVD)2-Rh 110 (trifluoroacetate salt)
(Z-Asp-Glu-Val-Asp)2-Rhodamine 110
A fluorogenic substrate for caspase-3 -
GC40120
Mca-LEVDGW-K(Dnp)-NH2 (trifluoroacetate salt)
Mca-Leu-Glu-Val-Asp-Gly-Trp-Lys(Dnp)-NH2
A fluorogenic substrate for caspase-4 -
GC40119
Z-YVADLD-FMK (trifluoroacetate salt)
Z-Tyr-Val-Ala-Asp-Leu-Asp-FMK
A peptide -
GC40118
Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt)
Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-CHO, Caspase-8 Inhibitor I
An inhibitor of caspase-8 and granzyme B -
GC40116
Aranorosin
A fungal metabolite
-
GC40094
all-trans Retinoic Acid-d5
atRA-d5, RA-d5, Vitamin A Acid-d5
An internal standard for the quantification of all-trans retinoic acid -
GC40085
Pazopanib-d6
培唑帕尼-d6,GW786034-d6
An internal standard for the quantification of pazopanib -
GC40076
(-)-Voacangarine
NSC 306219, (-)-Voacristine
A cytotoxic indole alkaloid -
GC40067
Herbimycin C
除莠霉素C
A bacterial metabolite -
GC40065
Meloxicam-d3
美洛昔康 d3
An internal standard for the quantification of meloxicam -
GC40061
Pestalotin
(-)-Pestalotin
A fungal metabolite with diverse biological activities -
GC40022
Roridin E
A trichothecene mycotoxin
-
GC40009
Bostrycin
Rhodosporin
An anthraquinone with diverse biological activities -
GC40007
Malformin A
Malformin A1
A cyclopentapeptide fungal metabolite with diverse biological activities -
GC34389
PUMA BH3
PUMABH3是一种p53正向凋亡调控因子(PUMA)BH3结构域多肽,作为Bak的直接激活剂,Kd值为26nM。
-
GC34303
Taltobulin hydrochloride (HTI-286 hydrochloride)
An inhibitor of microtubule polymerization
-
GC34263
Bak BH3
BakBH3是一种多肽,源于Bak蛋白的BH3结构域,在细胞中,能够抑制Bcl-xL的活性。
-
GC34218
Nivolumab (BMS-936558)
纳武单抗; BMS-936558; ONO-4538; MDX-1106
Nivolumab 是一种抗癌单克隆抗体,是一种程序性死亡受体-1 阻断人 IgG4 抗体,用于治疗晚期(转移性)非小细胞肺癌。 -
GC34214
Adalimumab (Anti-Human TNF-alpha, Human Antibody)
阿达木单抗; Anti-Human TNF-alpha, Human Antibody
阿达木单抗(抗人 TNF-α,人抗体)是治疗类风湿性关节炎的主要疗法之一。
-
GC34181
Tauroursodeoxycholate (TUDCA)
牛磺熊去氧胆酸; Tauroursodeoxycholic acid; TUDCA; UR 906
牛磺酸脱氧胆酸盐(TUDCA)是包括肝细胞在内的多种细胞的细胞保护剂,也是癌症细胞凋亡的诱导剂。 -
GC34177
Sesamol
芝麻酚
A lignan with diverse biological activities -
GC34172
AP1867
AP1867是合成的FKBP12F36V的配体。
-
GC34157
Desacetylcinobufotalin (Deacetylcinobufotalin)
去乙酰华蟾蜍它灵,Deacetylcinobufotalin
Desacetylcinbufotalin (Deacetylcinbufotalin) 是一种天然化合物;凋亡诱导剂,对HepG2细胞有明显抑制作用,IC50值为0.0279μ;mol/ml。 -
GC34134
Glycocholic acid
甘氨胆酸
Glycocholic acid是一种参与脂肪乳化的结晶胆汁酸,是胆酸与甘氨酸的结合物,它以钠盐的形式存在于哺乳动物的胆汁中。 -
GC34125
(E)-[6]-Dehydroparadol
(E)-[6]-Dehydroparadol来自专利US9272994化合物M15,能够抑制人体癌细胞生长并且诱导细胞凋亡。在HCT-116和H-1299细胞中的IC50值分别为43.02和41.59μM。
-
GC34096
(R)-(-)-Gossypol acetic acid (AT-101 (acetic acid))
(R)-(-)-醋酸棉酚; AT-101 (acetic acid); (-)-Gossypol acetic acid; (R)-Gossypol acetic acid
(R)-(-)-Gossypol (AT-101) acetic acid, the R-(-) enantiomer of Gossypol acetic acid, binds with Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.32 μM, 0.48 μM and 0.18 μM in cell-free assays; does not inhibit BIR3 domain and BID. AT-101 simultaneously triggers apoptosis and a cytoprotective type of autophagy. Phase 2. -
GC34095
ONC212
A GPR132 agonist
-
GC34093
SAFit2
An FKBP51 inhibitor
-
GC34092
Glycochenodeoxycholic acid (Chenodeoxycholylglycine)
甘氨鹅脱氧胆酸; Chenodeoxycholylglycine
A quantitative analytical standard guaranteed to meet MaxSpec? identity, purity, stability, and concentration specifications -
GC34070
Brusatol
鸦胆子苦醇; NSC 172924
Brusatol是一种Nrf2抑制剂,由从鸦嘴茅中分离提取。 -
GC34057
TBHQ (tert-Butylhydroquinone)
特丁基对苯二酚; tert-Butylhydroquinone
TBHQ(tert-Butylhydroquinone)是一种强效的酚类抗氧化剂,能够减轻氧化应激和炎症反应。 -
GC34021
Vitamin K4 (acetomenaphthone)
维生素K4; acetomenaphthone
A synthetic form of vitamin K -
GC34010
Danshensu (Dan shen suan A)
丹参素; Dan shen suan A; Salvianic acid A
丹参素是丹参的一种活性成分,通过激活 Nrf2 信号通路显示出广泛的心血管益处。 -
GC33934
DCVC
S-[(1E)-1,2-dichloroethenyl]--L-cysteine
DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine) 是三氯乙烯 (TCE) 的生物活性代谢物。 -
GC33831
Lidocaine hydrochloride (Lignocaine hydrochloride)
盐酸利多卡因; Lignocaine hydrochloride
An Analytical Reference Standard -
GC33826
C 87
C87是一种新型小分子TNFα抑制剂;高效抑制TNFα诱导的细胞毒性,IC50值为8.73μM。
-
GC33825
Taurochenodeoxycholic acid (12-Deoxycholyltaurine)
牛磺鹅去氧胆酸; 12-Deoxycholyltaurine
A quantitative analytical standard guaranteed to meet MaxSpec identity, purity, stability, and concentration specifications
-
GC33815
4-Hydroxyphenylacetic acid
4-羟基苯乙酸
A phenolic acid with anti-inflammatory and anti-steatotic activities -
GC33779
Cysteamine (β-Mercaptoethylamine)
巯基乙胺
2-Aminoethanethiol (cysteamine, β-Mercaptoethylamine, 2-Mercaptoethylamine, Thioethanolamine, Mercaptamine) is a radiation-protective agent that oxidizes in air to form cystamine. -
GC33699
SAFit1
SAFit1是一种特异性的FK506结合蛋白51(FKBP51)抑制剂,Ki为4±0.3nM。
-
GC33620
Nec-4
Nec-4,一个三环衍生物,是受体相互作用蛋白1(RIP1)的一个有效抑制剂,其IC50值为2.6μM,Ki值为0.46μM。
-
GC33501
Bornyl acetate
(-)-乙酸龙脑酯; L-(-)-Bornyl acetate
An acetate form of borneol -
GC19485
DC661
A PPT1 inhibitor
-
GC33407
BM 957
BM957是Bcl-2和Bcl-xL的有效抑制剂,其Ki值分别为1.2,<1nM,IC50值分别为5.4,6.0nM。
-
GC33401
S55746 hydrochloride (BLC201 (hydrochloride))
BCL201 hydrochloride
S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 是一种有效的,具有口服活性的选择性 BCL-2 抑制剂,Ki 为 1.3 nM,Kd 为 3.9 nM。 S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 具有低毒的抗肿瘤活性。 -
GC33384
DPBQ
DPBQ是一种p53激活剂。
-
GC33364
Mcl1-IN-4
Mcl1-IN-4是Mcl1的抑制剂,IC50值为0.2μM。
-
GC33356
AM-8735
AM-8735是有效,选择性的MDM2抑制剂,IC50值为25nM。
-
GC33347
Mcl1-IN-3
Mcl1-IN-3是Mcl1的抑制剂,来自专利专利WO2015153959A2,化合物实例57;IC50和Ki值分别为0.67和0.13μM。
-
GC33337
CDC801
CDC801是一种强效的磷酸二酯酶4(PDE4)和肿瘤坏死因子-α(TNF-α)抑制剂。IC50分别为1.1μM和2.5μM。